By Professor Elgene Lim

Conference Posters

Turner NC; Loi S; Moore HM; Chang C-W; Eng-Wong J; Bardia A; Boni V; Sohn J; Jhaveri KL; Lim E, 2021, 'Activity and biomarker analyses from a phase Ia/b study of giredestrant (GDC-9545; G) with or without palbociclib (palbo) in patients with estrogen receptor-positive, HER2-negative locally advanced/metastatic breast cancer (ER+/HER2-LA/mBC)', TX, San Antonio, Vol. 82, presented at San Antonio Breast Cancer Symposium, TX, San Antonio, 07 December 2021 - 10 December 2021, http://dx.doi.org/10.1158/1538-7445.SABCS21-PD13-07

Back to profile page